Avingtrans completes acquisition of Adaptix Ltd

Avingtrans plc (LON:AVG) has announced that, further to its announcement on 13 July 2023 and following approval under the UK National Security & Investment Act,

it has completed the acquisition of the remaining issued and to be issued share capital of Adaptix Ltd, the emerging MedTech business based in Oxford, for a total consideration of up to £2.7m to be satisfied by the issue of 642,355 ordinary shares of 5p each in the Company at 426 pence per Ordinary Share.

Avingtrans has been supporting Adaptix over the past few months through a loan facility from the Company of £1.1m and has agreed to adopt debt facilities of £2.1m. In addition to repaying a renegotiated sum to various debt and creditors of £2.2m on behalf of Adaptix.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Share on facebook
    Facebook
    Share on twitter
    Twitter
    Share on linkedin
    LinkedIn
    Avingtrans

    More articles like this

    Avingtrans

    Avingtrans’ Hayward Tyler acquires Slack & Parr

    Avingtrans plc (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, has announced that its subsidiary Hayward Tyler Fluid Handling Limited has completed the acquisition of certain assets

    Avingtrans

    Avingtrans to acquire remaining capital in Adaptix

    Avingtrans plc (LON:AVG), the engineering technology group, has announced a trading update in respect of the financial year ended 31 May 2023. The Board is pleased to report that the results for the year ended 31 May 2023 are expected to

    Avingtrans

    Avingtrans looking to strengthen the portfolio further (LON:AVG)

    Avingtrans’ Steve McQuillan discusses interim results, the performance of the main divisions, their medical division, stronger than average order book and what investors can expect in the coming year from the company in this exclusive interview with DirectorsTalk.

    Avingtrans

    Avingtrans appoints Willem Baralt as its new Chairman

    Avingtrans PLC (LON:AVG) has announced that further to the statement made on 14 December 2022, Adaptix, the Oxford based emerging MedTech Company, has appointed Willem Baralt as its new Chairman. Willem, previously of Quanta Dialysis Technologies, will succeed

    Avingtrans

    Avingtrans investee Adaptix receives 10(k) clearance from FDA

    Avingtrans PLC (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, announces that medical imaging technology associate company Adaptix Limited (Adaptix) has received 510(k) clearance from the U.S.

    Avingtrans

    Avingtrans ownership in Magnetica will increase to 74%

    Avingtrans PLC (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, has announced that shareholders of Magnetica have approved an increase to Avingtrans’ ownership as part of a capital

    Avingtrans

    Avingtrans acquires the business and assets of Hevac

    Avingtrans PLC (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, has announced that trading in the first 6 months of the financial year to 30 November 2022 was

    Avingtrans

    Avingtrans deliver solid results and a confident outlook (VIDEO)

    Avingtrans PLC (LON:AVG) CEO Steve McQuillan joins DirectorsTalk Interviews to discuss its results for the year ended 31st May 2022. Steve talks us through the highlights, the performance and highlights in the Energy division, involvement in the Medical division,

    Avingtrans

    Avingtrans revenue from continuing operations increased by 1.9% to £100.4m

    Avingtrans PLC (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, has announced its preliminary results for the year ended 31 May 2022. Financial Highlights ·      Revenue from

    Avingtrans

    Avingtrans’ Hayward Tyler awarded $7m nuclear contracts

    Avingtrans PLC (LON:AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, has announced Hayward Tyler, Inc has secured two new nuclear contracts worth a total of US

    Avingtrans

    Avingtrans results, visibility and M&A opportunities (Interview)

    Avingtrans PLC (LON:AVG) CEO Steve McQuillan joins DirectorsTalk Interviews to discuss its interim results for the six months ended 30 November 2021. Steve talks us through the highlights, its strong order book, updates us on the developments with Hayward

    No more posts to show